Added to YB: 2024-05-20
Pitch date: 2024-05-20
BTMD:US [bearish]
biote Corp.
+51.26%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance.
Market Cap
$81.3M
Pitch Price
$5.54
Price Target
N/A
Dividend
N/A
EV/EBITDA
4.20
P/E
3.23
EV/Sales
0.85
Sector
Pharmaceuticals
Category
N/A
Show full summary:
biote Corp. Class A BTMD:US
A summary for this pitch has not been created yet.
Read full article (0 min)